ICM
CAH icon

Invenomic Capital Management’s Cardinal Health CAH Stock Holding History

Invenomic Capital Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-55,100
Closed -$2.59M – 146
2020
Q3 		$2.59M Buy
+55,100
New +$2.83M 1.43% 20

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's CAH Position: Q3 2022 in Review

Invenomic Capital Management sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 342,941 shares — an estimated $17.9M sold.

Invenomic Capital Management first reported a position in CAH in Q2 2020 and held it in 9 quarters. The position peaked at $17.9M in Q2 2022. 850 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

  • Invenomic Capital Management reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 342,941 Cardinal Health shares in Q3 2022, an estimated $17.9M.
  • Invenomic Capital Management first reported a position in Cardinal Health in Q2 2020 and held it in 9 quarters.
  • Invenomic Capital Management's Cardinal Health position peaked at $17.9M in Q2 2022.
  • 850 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.